The a2 Milk Company to defend class action
NZX Code: ATM
ASX Code: A2M
The a2 Milk Company Limited
www.thea2milkcompany.com
18 May 2022
NZX/ASX Market Release
The a2 Milk Company to defend class action
The a2 Milk Company Limited ("the Company") has previously announced that group proceedings had been filed in
the Supreme Court of Victoria by Slater & Gordon Lawyers on 6 October 2021 and by Shine Lawyers on 24
November 2021, which named the Company as the defendant.
Today the Company has been notified that a representative proceeding has been filed in the High Court of New
Zealand, which names the Company as the defendant.
The proceeding, filed by Thorn Law, and funded by CHC Investment Fund III Pty Limited, relates to the same period
(19 August 2020 to 9 May 2021) and makes allegations that are broadly similar to those advanced by the two class
actions filed in the Supreme Court of Victoria.
The Company considers that it has at all times complied with its disclosure obligations, denies any liability and will
vigorously defend the proceedings.
Authorised for release by
David Bortolussi
Managing Director and CEO
The a2 Milk Company Limited
For further information, please contact:
Investors / Analysts
David Akers
Group Head of Investor Relations and Sustainability
M +61 412 944 577
david.akers@a2milk.com
Rebecca Culbertson
Senior Analyst Investor Relations
M +61 400 955 295
rebecca.culbertson@a2milk.com
Media
Rick Willis
M +61 411 839 344
rick@networkfour.com.au
Media – New Zealand
Barry Akers
M +64 21 571 234
akers@senescallakers.co.nz
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- AFT — AFT Pharmaceuticals Limited: AFT full year results FY20222022-05-22
“Results for announcement to the market AFT Pharmaceuticals Limited Reporting Period 12 months to 31 March 2022 Previous Reporting Period 12 months to 31 March 2021 Currency NZ$ Amount (000s) Percentage change Revenue from continuing operations $130,314 Up 15% T…”
- AFT — AFT Pharmaceuticals Limited: AFT prevails in comparative advertising judgement2022-04-07
“AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622, New Zealand Incorporated in New Zealand ARBN: ARBN 609 017 969 investor.relations@aftpharm.com 8 April 2022 AFT prevails in comparative advertising jud…”
- AFT — AFT Pharmaceuticals Limited: AFT 2022 ASM chairman’s address and presentation2022-08-04
“We spent over $10 million on further research and development last financial year. And we continued to work with educational and research institutions including contributing $100,000 to the University of Auckland Medical Health Sciences Foundation for ana…”